期刊文献+

影响胃肠间质瘤完全切除术后复发转移及预后的相关生物标志物研究 被引量:7

Study on associated biomarkers influencing recurrence, metastasis and prognosis in patients with gastrointestinal stromal tumors after complete resection
原文传递
导出
摘要 目的探讨影响胃肠间质瘤(GIST)完全切除术后复发转移及预后的生物标志物。方法收集1990年1月至2008年12月中山大学肿瘤防治中心148例完全切除术后的GIST标本.利用免疫组织化学技术、以组织芯片为载体,检测Ki-67、E-cadherin、MMP7、CD44、nm23、P53、Survivin、CyclinD1、COX.2和VEGF共10个生物指标,研究其表达与GIST完全切除术后复发转移和预后的关系。结果单因素预后分析(Log-rank检验)结果显示,Ki-67、E-cadherin、MMP7、CD44、P53和Survivin与GIST术后无瘤生存有关(均P〈0.05),Kj-67、E-cadherin、P53和Survivin与总体生存有关(均P〈0.05)。多因素预后分析(Cox回归模型)结果显示,Ki.67、CD44和P53是影响GIST完全切除术后复发转移的独立因素(均P〈0.05);Ki-67是影响术后生存的独立因素(P〈0.05)。结论Ki.67、CD44和P53与GIST完全切除术后复发转移密切相关.Ki-67还能提示预后。 Objective To explore the associated biomarkers influencing recurrence, metastasis and prognosis in patients with gastrointestinal stromal tumors (GIST) after complete resection. Methods Tumor tissue samples of 148 patients with GIST undergoing complete resection from January 1990 to December 2008 in Sun Yat-sen University Cancer Center were collected. The expressions of Ki-67, E-cadherin, MMP7, CD44, nm23, P53, survivin, Cyclin D1, COX-2, and VEGF in tumor tissue samples were detected by tissue microarray and immunohistochemistry (IHC). The association of above factors expressions with recurrence, metastasis and prognosis was examined. Results Log-rank test showed that Ki-67, E-cadherin, MMP7, CD44, P53 and survivin were associated to disease-free duration after complete GIST resection(all P〈0.05), and the Ki-67, E-cadherin, P53 and survivin were associated to overall survival (all P〈0.05). Cox multivariate analysis revealed that disease-free survival was associated with Ki-67, CD44 and P53 (all P〈0.05), and the overall survival was only associated with Ki-67(P〈0.05). Conclusion Ki-67, CD44 and P53 are closely associated with recurrence and metastasis after complete GIST resection, and Ki-67 can predict the prognosis of GIST.
出处 《中华胃肠外科杂志》 CAS CSCD 2013年第3期242-246,共5页 Chinese Journal of Gastrointestinal Surgery
关键词 胃肠间质瘤 外科手术 生物标志物 肿瘤复发 预后 Gastrointestinal stromal tumors Surgical procedures Biomarkers Neoplasmrecurrence Prognosis
  • 相关文献

参考文献23

  • 1Hassan I, You YN, Shyyan R, et al. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol, 2008,15 : 52-59. 被引量:1
  • 2Gold JS, Dematteo RP. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg, 2006,44: 176-184. 被引量:1
  • 3薄林会,刘文天.胃肠道间质瘤预后研究进展[J].国际内科学杂志,2007,34(6):335-338. 被引量:8
  • 4Ohsie SJ, Sarantopoulos GP, Cochran A J, et al. Immunohisto- chemical characteristics of melanoma. J Cutan Pathol, 2008,35: 433. 被引量:1
  • 5张飞功,刘瑞,陈丹磊.p53,p21WAF1,Ki-67及PCNA在小肠间质瘤的表达及其意义[J].中国普通外科杂志,2009,18(4):406-408. 被引量:3
  • 6Ozguc H, Yilmazlar T, Yeric O. Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential. J Gastrointest Surg, 2005,9:418- 429. 被引量:1
  • 7黄文生,王天宝,伍虹,钟诗龙.Ki-67和survivin蛋白在胃肠间质瘤的表达与临床意义[J].中华胃肠外科杂志,2011,14(8):645-646. 被引量:3
  • 8Koon N, Schneider-Stock R, Sarlomo-Rikala M, et al. Molecular targets for tumour Progression in gastrointestinal stromal tumours. Gut, 2004,53 : 235-240. 被引量:1
  • 9Huang HY, Huang WW, Lin CN, et al. Immunohistochemical expression of plrIK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria. Ann Surg Oncol, 2006,13 : 1633-1644. 被引量:1
  • 10Nilsson B, Bumming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumors : the incidence, prevalence,clinical course, and prognostication in the preimatinib mesylate era (a population- based study in western Sweden). Cancer, 2005,103 : 821-829. 被引量:1

二级参考文献69

共引文献29

同被引文献56

  • 1Li-Cheng Liu,Wen-Tong Xu,Xin Wu,Po Zhao,Ya-Li Lv,Lin Chen.Overexpression of carbonic anhydrase Ⅱ and Ki-67 proteins in prognosis of gastrointestinal stromal tumors[J].World Journal of Gastroenterology,2013,19(16):2473-2480. 被引量:4
  • 2孙梅,张兴义,邹洪杰,孙亚欣,李东复.CyclinD1、Ki67和Bcl-2在胃肠道间质瘤的表达及与其预后的关系[J].中华胃肠外科杂志,2005,8(6):542-543. 被引量:6
  • 3詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:86
  • 4Cassier PA,Ducimetière F,Lurkin A,et al.A prospective epidemiological study of new incident GGISTs during two consecutive years in Rh(o)ne Alpes region:incidence and molecular distribution of GISTs in a European region[J] .Br J Cancer,2010,103(2):165-170. 被引量:1
  • 5Sandvik OM,S(o)reide K,Kval(o)y JT,et al.Epidemiology of gastrointestinal stromal tumours:single-institution experience and clinical presentation over three decades[J] .Cancer Epidemiol,2011,35(6):515-520. 被引量:1
  • 6ESMO/European Sarcoma Network Working Group.Gastrointestinal stromal tumors:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J] .Ann Oncol,2012,23(Supple 7):vii49-vii55. 被引量:1
  • 7Joensuu H,Vehtari A,Riihim(a)ki J,et al.Risk of recurrence of gastrointestinal stromal tumour after surgery:an analysis of pooled population-based cohorts[J] .Lancet Oncol,2012,13(3):265-274. 被引量:1
  • 8Demetri GD,Benjamin RS,Blanke CD,et al.NCCN Task Force report:management of patients with gastrointestinal stromal tumor(GISTs)-update of NCCN clinical practice guidelines[J] .J Natl Compr Canc Netw,2007,5(Suppl 2):S1-S29,quiz S30. 被引量:1
  • 9Novitsky YW,Kercher KW,Sing RF,et al.Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors[J] .Ann Surg,2006,243(6):738-745. 被引量:1
  • 10Wan P,Li C,Yan M,et al.Laparoscopy-assisted versus open surgery for gastrointestinal stromal tumors of jejunum and ileum:perioperative outcomes and long-term follow-up experience[J] .Am Surg,2012,78(12):1399-1404. 被引量:1

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部